A complex of the five-membered transition structure for intramolecular cyclization of 4,5-epoxyhexan-1-ol with the “Houk” theozyme which is 3.5 kcal/mol lower in energy than the complex previously reported as a model for the antibody IgG26D9 catalyzed intramolecular cyclization reverses the preference of that theozyme to favor furan formation. This shows the reported theozyme complex was not a global minima and therefore not a satisfactory model for the antibody reaction. We report a new theozyme favoring pyran formation consistent with the antibody result and the recently published crystal structure of the antibody Fab 5C8 with hapten.
No takes yet. Share an insight, caveat, or question.
Coxon et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: